Treatment with licochalcone A decreased the protein level of survivin, but not Bcl‐2, Bcl‐xL or Mcl‐1, robustly in either WT or mutant EGFR‐expressing NSCLC cells (Figure 4F). This evidence concerns the gene BCL2L1 and non-small cell lung carcinoma.